News and Trends 18 Jul 2023
Korro Bio and Frequency Therapeutics to merge
…the potential to advance genetic medicines beyond rare genetic diseases into larger patient populations with common diseases. About OPERA Korro Bio’s platform, OPERA (oligonucleotide promoted editing of RNA), builds on…